Phytomedicine,
Год журнала:
2024,
Номер
136, С. 156303 - 156303
Опубликована: Дек. 4, 2024
Abnormal
antioxidant
capacity
in
cancer
cells
is
intimately
linked
to
tumor
aggressiveness.
Modulating
oxidative
stress
status
and
inhibiting
ferroptosis
represents
a
novel
anticancer
therapeutic
strategy.
STAM
Binding
Protein
Like
1
(STAMBPL1),
deubiquitinase,
implicated
various
malignancies,
yet
its
function
potential
for
cholangiocarcinoma
(CCA)
remains
unexplored.
Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Дек. 4, 2024
The
SMAD-specific
E3
ubiquitin
protein
ligase
2
(SMURF2)
has
emerged
as
a
critical
regulator
in
cancer
biology,
modulating
the
stability
of
Hypoxia-Inducible
Factor
1-alpha
(HIF1α)
and
influencing
network
hypoxia-driven
pathways
within
tumor
microenvironment
(TME).
SMURF2
targets
HIF1α
for
ubiquitination
subsequent
proteasomal
degradation,
disrupting
hypoxic
responses
that
promote
cell
survival,
metabolic
reprogramming,
angiogenesis,
resistance
to
therapy.
Beyond
its
role
regulation,
exerts
extensive
control
over
cellular
processes
central
progression,
including
chromatin
remodeling,
DNA
damage
repair,
ferroptosis,
stress
responses.
Notably,
SMURF2's
ability
ferroptotic
death
through
GSTP1
degradation
offers
an
alternative
pathway
overcome
apoptosis
resistance,
expanding
therapeutic
options
refractory
cancers.
This
review
delves
into
multifaceted
interactions
between
HIF1α,
emphasizing
how
their
interplay
impacts
adaptations
like
Warburg
effect,
immune
evasion,
resistance.
We
discuss
dual
functionality
both
suppressor
and,
certain
contexts,
oncogenic
factor,
underscoring
potential
highly
versatile
target.
Furthermore,
SMURF2-HIF1α
axis
presents
innovative
approach
destabilize
hypoxia-dependent
pathways,
sensitizing
tumors
chemotherapy,
radiotherapy,
immune-based
treatments.
However,
complexity
necessitate
thorough
assessment
off-target
effects
challenges
specificity,
which
must
be
addressed
optimize
clinical
application.
concludes
by
proposing
future
directions
research
pathway,
aiming
refine
targeted
strategies
exploit
this
address
adaptive
mechanisms
aggressive
tumors,
ultimately
advancing
landscape
precision
oncology.
Journal of Agricultural and Food Chemistry,
Год журнала:
2024,
Номер
72(29), С. 16152 - 16162
Опубликована: Июль 11, 2024
Polyunsaturated
fatty
acids
(PUFAs)
are
essential
nutrients
for
the
human
body,
playing
crucial
roles
in
reducing
blood
lipids,
anti-inflammatory
responses,
and
anticancer
effect.
Quinoa
is
a
nutritionally
sound
food
source,
rich
PUFAs.
This
study
investigates
role
of
quinoa
polyunsaturated
(QPAs)
on
quelling
drug
resistance
colorectal
cancer.
The
results
reveal
that
QPA
downregulates
expression
drug-resistant
proteins
P-gp,
MRP1,
BCRP,
thereby
enhancing
sensitivity
cancer
cells
to
chemotherapy
drug.
also
inhibits
stemness
by
marker
CD44.
Consequently,
it
suppresses
downstream
protein
SLC7A11
leads
ferroptosis.
Additionally,
makes
ferritin
lower
increases
concentration
free
iron
ions
within
cells,
leading
Overall,
has
dual-function
reversing
simultaneously
inhibiting
inducing
provides
new
option
sensitizers
establishes
theoretical
foundation
development
utilization
quinoa.
The FASEB Journal,
Год журнала:
2024,
Номер
38(17)
Опубликована: Сен. 1, 2024
Abstract
Glutathione
S‐transferase‐Pi
1
(GSTP1)
is
an
isozyme
that
plays
a
key
role
in
detoxification
and
antioxidative
damage.
It
also
confers
resistance
to
tumor
therapy.
However,
the
specific
of
GSTP1
radiotherapy
pancreatic
cancer
(PC)
not
known.
In
this
study,
we
investigated
how
imparts
radioresistance
PC.
The
findings
previous
studies
study
revealed
ionizing
radiation
(IR)
induces
ferroptosis
cells,
primarily
by
upregulating
expression
ACSL4.
Our
results
showed
after
IR,
prolonged
survival
cells
inhibiting
but
did
affect
apoptosis.
reduced
cellular
decreasing
levels
ACSL4
increasing
GSH
content.
These
changes
increase
xenograft
tumors
IR.
indicate
participates
irradiation‐induced
cell
death
prevents
IR‐induced
ferroptosis.
Phytomedicine,
Год журнала:
2024,
Номер
136, С. 156303 - 156303
Опубликована: Дек. 4, 2024
Abnormal
antioxidant
capacity
in
cancer
cells
is
intimately
linked
to
tumor
aggressiveness.
Modulating
oxidative
stress
status
and
inhibiting
ferroptosis
represents
a
novel
anticancer
therapeutic
strategy.
STAM
Binding
Protein
Like
1
(STAMBPL1),
deubiquitinase,
implicated
various
malignancies,
yet
its
function
potential
for
cholangiocarcinoma
(CCA)
remains
unexplored.